CLINICAL_TRIALS
trial_result
· 2024-02-08
Clinical Trial Update: A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide [Phase 1]
Summary
Phase 1 trial evaluating energy expenditure and food intake in obesity using tirzepatide has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2024-02-08